Guoping Zheng

Guoping Zheng


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
HWHeng Wang
Heng Wang
KFKeyi Fan
Keyi Fan
YLYaling Li
Yaling Li
ZWZiyan Wang
Ziyan Wang
SWShule Wang
Shule Wang
GZGuoping Zheng
Guoping Zheng
Introduction: Pan-arterial diseases, including atherosclerosis (AS), aortic aneurysm and dissection (AAD), and peripheral arterial disease (PAD), impose a substantial global health burden. Although ambient temperature has been implicated in individual arterial conditions, its association with mortality across the pan-arterial spectrum remains incompletely understood. Objective: To evaluate the association between ambient temperature and mortality from pan-arterial diseases across the United States. Methods: We analysed mortality data for adults aged ≥ 25 years with AS, AAD, or PAD in the United States CDC WONDER database from 1999 to 2023. Age-adjusted mortality rates (AAMR) and average annual percent change (AAPC) were estimated. Monthly air-temperature metrics (1999– 2023) were linked at the United States Census region level. Seasonal variation was assessed using analysis of variance. Associations between temperature and mortality were examined using Spearman correlation, Poisson regression with lag structures, and distributed lag non-linear models (DLNM), with results expressed as relative risks (RR) per 10°F increase in temperature. Results: Between 1999 and 2023, AAMRs declined for AS, AAD, and PAD, yet mortality burden remained substantial. Mortality from all three conditions was consistently higher in winter than in summer across Census regions. Monthly mean temperature was inversely correlated with crude mortality for pan-arterial diseases (P < 0.05). In the Northeast, cumulative RR per +10°F across lags 0– 3 months was 0.919 for AS, 0.945 for AAD, and 0.953 for PAD, with similar patterns observed in other regions. DLNM analyses demonstrated a predominantly cold-related excess risk, with acute effects and regional heterogeneity at higher temperatures. Conclusion: Lower ambient temperatures are associated with increased mortality from pan-arterial diseases in the United States. These findings highlight shared vulnerability to cold exposure across arterial diseases and support winter-focused preventive and healthcare preparedness strategies.

27 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
TGTingting Gao
Tingting Gao
RGruiyuan gu
ruiyuan gu
HWHeng Wang
Heng Wang
LLLizheng Li
Lizheng Li
JHjie hu
jie hu
HDHonglin Dong
Honglin Dong
Background: Contrast-induced acute kidney injury (CIAKI) is a common complication in hospital-acquired renal conditions, yet its pathogenesis remains unclear and effective treatments are limited. Intermedin (IMD), a peptide related to the calcitonin gene, exhibits vasodilatory and endothelial barrier-stabilizing effects via the calcitonin receptor-like receptor (CLR). However, the potential of IMD in mitigating CIAKI has not been thoroughly investigated. Aims: This study aimed to delineate the protective role of IMD in CIAKI through both in vitro and in vivo models, with a particular focus on elucidating the underlying mechanisms, specifically the cAMP/Rac1 signaling pathway. Methods: Human umbilical vein endothelial cells (HUVECs) were treated with iohexol to simulate kidney injury in vitro. The protective effects of IMD were evaluated using the CCK8 assay, flow cytometry, ELISA, and western blotting. A CIAKI rat model was developed to assess renal peritubular capillary endothelial cell injury and renal function using a range of techniques, including histopathology, immunohistochemistry, immunofluorescence, western blotting, and transmission electron microscopy. Results: In vitro, IMD significantly enhanced HUVEC viability and mitigated iohexol-induced toxicity by preserving intercellular adhesion junctions and activating the cAMP/Rac1 pathway. The protective effects of IMD were attenuated by Rac1 inhibition. In vivo, CIAKI caused considerable damage to peritubular capillary endothelial cell junctions, leading to impaired renal function. IMD treatment markedly improved renal function, an effect that was abolished by Rac1 inhibition. Conclusion: IMD protects against renal injury in CIAKI by activating the cAMP/Rac1 pathway, thereby preserving the integrity of peritubular capillary endothelial cells and mitigating acute renal injury induced by contrast media. These findings underscore the therapeutic potential of IMD in CIAKI and emphasize the critical role of the cAMP/Rac1 pathway in renal protection.

6 March 2026 in Brain & Heart
Verified
Journal Article
Open access
PDF file
HWHeng Wang
Heng Wang
YLYaling Li
Yaling Li
KFKeyi Fan
Keyi Fan
QTQinqin Tian
Qinqin Tian
ZWZiyan Wang
Ziyan Wang
GZGuoping Zheng
Guoping Zheng
In-stent neoatherosclerosis (ISNA) has emerged as a major cause of late stent failure, yet its underlying mechanisms remain poorly understood. Clinical and imaging studies indicate that ISNA develops more rapidly and exhibits greater plaque vulnerability than native atherosclerosis, a phenomenon often described as “late catch-up.” Trained immunity (TRIM), a form of innate immune memory driven by metabolic and epigenetic reprogramming, has been increasingly implicated in atherosclerotic cardiovascular diseases but has not previously been linked to ISNA. In this article, we propose a novel hypothesis that ISNA is driven by TRIM in vascular resident cells and innate immune cells within the stented arterial microenvironment. Pre-existing atherosclerotic risk factors may establish central and peripheral TRIM, which can be reactivated by persistent proatherogenic conditions and stent-related stimuli. The rapid recall and amplified secondary responses characteristic of TRIM provide a plausible explanation for the accelerated progression and instability of ISNA lesions. This perspective highlights TRIM as a promising mechanistic framework and therapeutic target for the prevention and management of ISNA.